Genetic and epigenetic profiling of the BRCA1 / 2 genes in solitary ovarian cancer and multiple primary ovarian tumors by M. E. Esenova, Yu. G. Payanidi, S. V. Vinokurova, A. S. Shevchuk, M. N. Tikhonovskaya, K. I. Zhordania

Subjects: Get full text

Never tear us a-PARP: Dealing with DNA lesions during mitosis by Pepijn M. Schoonen, Marcel A.T.M. van Vugt

Subjects: Get full text

Detection of BRCA1/2 pathogenic variants in patients with breast and/or ovarian cancer and their families. Analysis of 3,458 cases from Lower Silesia (Poland) according to the diag... by Anna Doraczynska-Kowalik, Anna Doraczynska-Kowalik, Dagmara Michalowska, Rafal Matkowski, Rafal Matkowski, Ewelina Czykalko, Dorota Blomka, Mariola Semeniuk, Mariola Abrahamowska, Gabriela Janus-Szymanska, Gabriela Janus-Szymanska, Paulina Mlynarczykowska, Bartlomiej Szynglarewicz, Bartlomiej Szynglarewicz, Ireneusz Pawlak, Adam Maciejczyk, Adam Maciejczyk, Izabela Laczmanska, Izabela Laczmanska

Subjects: Get full text

Facing inevitable PARPis resistance: Mechanisms and therapeutic strategies for breast cancer treatment by Haixia Liu, Xiaohui Chen, Yimin Jia, Hengyi Chen, Xiaohui Wang, Guoxiang Liu, Yang Luo

Subjects: “…BRCA1/2…”
Get full text

An in-depth exploration of the post-test informational needs of BRCA1 and BRCA2 pathogenic variant carriers in Asia by Yuen, Jeanette, Fung, Si Ming, Sia, Chin Leong, Venkatramani, Mallika, Shaw, Tarryn, Courtney, Eliza, Li, Shao-Tzu, Chiang, Jianbang, Tan, Veronique Kiak-Mien, Tan, Benita Kiat-Tee, Ngeow, Joanne

Subjects: Get full text

Clinical and morphological characteristics and prognosis of BRCA-associated breast cancer in women of the reproductive age by D. E. Avtomonov, A. A. Parokonnaya, L. N. Lyubchenko, M. I. Nechushkin, N. I. Pospekhova

Subjects: Get full text

Ovarian Cancer and BRCA1/2 Testing: Opportunities to improve clinical care and disease prevention by Katherine eKarakasis, Julia eBurnier, Valerie eBowering, Amit eOza, Stephanie eLheureux

Subjects: Get full text

Pregnancy after breast cancer in BRCA1/2 mutation carriers by Jelena Maksimenko, Arvīds Irmejs, Jānis Gardovskis

Subjects: Get full text

Complex Interplay between DNA Damage and Autophagy in Disease and Therapy by Aman Singh, Naresh Ravendranathan, Jefferson C. Frisbee, Krishna K. Singh

Subjects: Get full text

Risk‐reducing mastectomy decisions among women with mutations in high‐ and moderate‐ penetrance breast cancer susceptibility genes by Jacob G. Comeaux, Julie O. Culver, John E. Lee, Danielle Dondanville, Heather L. McArthur, Emily Quinn, Nicholas Gorman, Charité Ricker, Ming Li, Caryn Lerman

Subjects: “…BRCA1/2…”
Get full text

Prevalence and reclassification of BRCA1 and BRCA2 variants in a large, unselected Chinese Han breast cancer cohort by Yun Liu, Honglian Wang, Xin Wang, Jiaqi Liu, Junjian Li, Xiang Wang, Yun Zhang, Zhigang Bai, Qinghua Zhou, Ying Wu, Yi Shen, Xiaoling Weng, Fatao Liu, Jiancheng Guo, Lijun Di, Olivier Gires, Zhongtao Zhang, Yiding Chen, Hongxia Wang

Subjects: Get full text

Ultrasound guided needle biopsy of axilla to evaluate nodal metastasis after preoperative systemic therapy in cohort of 106 breast cancers enriched with BRCA1/2 pathogenic variant... by Baiba Līcīte, Arvīds Irmejs, Jeļena Maksimenko, Pēteris Loža, Genādijs Trofimovičs, Edvīns Miklaševičs, Jurijs Nazarovs, Māra Romanovska, Justīne Deičmane, Reinis Irmejs, Gunta Purkalne, Jānis Gardovskis

Subjects: “…Breast cancer neoadjuvant axilla cytology BRCA1/2…”
Get full text

BRCA1/2 mutations and survival of high-grade endometrioid endometrial cancer by Yibo Dai, Jingyuan Wang, Luyang Zhao, Zhiqi Wang

Subjects: Get full text

BRCA1/2 testing among young women with breast cancer in Massachusetts, 2010–2013: An observational study using state cancer registry and All‐Payer claims data by Lydia E. Pace, John Z. Ayanian, Robert E. Wolf, Richard Knowlton, Susan T. Gershman, Summer Sherburne Hawkins, Nancy L. Keating

Subjects: “…BRCA1/2…”
Get full text

Genetic counselling, BRCA1/2 status and clinico-pathologic characteristics of patients with ovarian cancer before 50 years of age by Cvelbar Mirjam, Hocevar Marko, Novakovic Srdjan, Stegel Vida, Perhavec Andraz, Krajc Mateja

Subjects: Get full text

Spectrum and prevalence of BRCA1/2 germline mutations in Pakistani breast cancer patients: results from a large comprehensive study by Muhammad Usman Rashid, Noor Muhammad, Humaira Naeemi, Faiz Ali Khan, Mariam Hassan, Saima Faisal, Sidra Gull, Asim Amin, Asif Loya, Ute Hamann

Subjects: “…BRCA1/2…”
Get full text

Cytology material is equivalent to tumor tissue in determining mutations of BRCA 1/2 genes in patients with tubo-ovarian high grade serous carcinoma by Andreja Gornjec, Srdjan Novakovic, Vida Stegel, Marko Hocevar, Ziva Pohar Marinsek, Barbara Gazic, Mateja Krajc, Erik Skof

Subjects: Get full text

Recent advancements in nanomaterial-based biosensors for diagnosis of breast cancer: a comprehensive review by Yalda Yazdani, Fereshtehsadat Jalali, Habib Tahmasbi, Mitra Akbari, Neda Talebi, Seyed Abbas Shahrtash, Ahmad Mobed, Mahsa Alem, Farhood Ghazi, Mehdi Dadashpour

Subjects: Get full text

Evaluation of an Italian Population-Based Programme for Risk Assessment and Genetic Counselling and Testing for BRCA1/2-Related Hereditary Breast and Ovarian Cancer after 10 Years... by Stefano Ferretti, Priscilla Sassoli de Bianchi, Debora Canuti, Cinzia Campari, Laura Cortesi, Valentina Arcangeli, Elena Barbieri, Cecilia D’Aloia, Rita Danesi, Pierandrea De Iaco, Margherita De Lillo, Laura Lombardo, Gabriella Moretti, Antonino Musolino, Dante Palli, Caterina Palmonari, Mila Ravegnani, Alfredo Tafà, Alessandra Tononi, Daniela Turchetti, Claudio Zamagni, Valentina Zampiga, Lauro Bucchi, the HBOC Study Group

Subjects: “…BRCA1/2…”
Get full text

Screening of BRCA1/2 variants in Mauritanian breast cancer patients by Selma Mohamed Brahim, Ekht Elbenina Zein, Crystel Bonnet, Cheikh Tijani Hamed, Malak Salame, Mohamed Vall Zein, Meriem Khyatti, Ahmedou Tolba, Ahmed Houmeida

Subjects: Get full text